Chlorophyllide Cu complex sodium salt
CAS 11006-34-1
Chlorophyllide Cu complex sodium salt (CAS 11006-34-1) is a pharmaceutical compound with 0 bioactivity targets and 6 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Chlorophyllide Cu complex sodium salt is linked to DTXSID1045956 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Chlorophyllide Cu complex sodium salt used for in pharmaceutical contexts?
Chlorophyllide Cu complex sodium salt (CAS 11006-34-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Chlorophyllide Cu complex sodium salt?
Chlorophyllide Cu complex sodium salt has 6 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Drug hypersensitivity, Dyspnoea, Hereditary angioedema, Injection site rash, Product use in unapproved indication. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Chlorophyllide Cu complex sodium salt also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Chlorophyllin-Copper Complex with EU status "permitted".
What clinical phase is Chlorophyllide Cu complex sodium salt in?
No phase 1-4 clinical development badge is rendered for Chlorophyllide Cu complex sodium salt because the matched compound identifier rows do not contain a max-phase value.